Multidisciplinary Research for the Prevention and Treatment of Joint Diseases
Joint diseases impact the quality of life of more than 40 million Americans and are among the leading causes of disability. Increases in incidences of joint diseases can be attributed to an aging baby boomer generation and high obesity rates.
The COBRE for Skeletal Health and Repair at Rhode Island Hospital enables clinicians, scientists, engineers and biologists to work side-by-side on multidisciplinary research, helping to better understand cartilage and joint health mechanisms and develop strategies for the prevention and treatment of skeletal joint diseases.
This year, Rhode Island Hospital’s Center of Biomedical Research Excellence (COBRE) in Skeletal Health and Repair was awarded a $5.8 million, five-year Phase III grant by the National Institute of General Medical Sciences to support ongoing research in the area of cartilage and joint diseases. In 2012, COBRE was awarded a $10.8 million NIH Phase II grant to fund studies of cartilage and joint health, and an $11 million NIH Phase I grant in 2007.
Says Qian Chen, PhD, director and principal investigator of the COBRE for Skeletal Health and Repair, "I am honored to continue lead this COBRE center and hope the research performed at Rhode Island Hospital, the Warren Alpert Medical School of Brown University and in the city of Providence will translate into newer and better treatments, cures and preventive techniques that will improve the health of all Americans."
Lifespan Research and Clinical Trials
Research is currently being conducted across Lifespan to learn more about bone and joint diseases affect our patients.
Learn more: Bone disease clinical trials and joint disease clinical trials at Lifespan